1998•Drug Development ResearchOpen access

US drug and biologic approvals in 1997

John F. Beary, John D. Siegfried, Renee Tavares

Abstract

The Prescription Drug User Fee Act of 1992 enhanced review resources for the Food and Drug Administration (FDA). The past two years have seen an unprecedented approval of 92 new drugs and 19 new biologics. Information is provided on the 49 new products approved by the FDA in 1997. Drug Dev. Res. 44:114–129, 1998. © 1998 Wiley-Liss, Inc.

Open-access reader

About this research paper

What this paper is about

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Food and drug administration, Drug, Drug approval, Medicine, Pharmacology, New drug application, Medical prescription, Approved drug